Paulson & Co 13F, Q2 2025

John Paulson · quarter ending 30 June 2025 · filed 14 August 2025 · SEC CIK 1035674

$2.01B
Filed US book
15
Positions
31.4%
Largest position

Common stock only: shares the fund reported owning at the quarter end, valued as filed.

Largest positions, Q2 2025

Weights are against the whole filed book. Changes are in shares held, against the Q1 2025 filing.

CompanyTickerValue% of bookvs Q1 2025
MADRIGAL PHARMACEUTICALS INCMDGL$632.37M31.4%unchanged
PERPETUA RESOURCES CORPPPTA$392.70M19.5%+31% shares
ACADIAN ASSET MANAGEMENT INCAAMI$315.40M15.7%unchanged
BAUSCH HEALTH COS INCBHC$218.39M10.9%+24% shares
NOVAGOLD RES INCNG$111.40M5.5%unchanged
AGNICO EAGLE MINES LTDAEM$93.19M4.6%unchanged
INTERNATIONAL TOWER HILL MINTHM$60.09M3.0%unchanged
THRYV HLDGS INCTHRY$52.04M2.6%unchanged
HONEYWELL INTL INCHONGBP$46.58M2.3%unchanged
SEABRIDGE GOLD INCSEA1EUR$30.06M1.5%unchanged
TRILOGY METALS INC NEWTMQ$19.34M1.0%unchanged
EQUINOX GOLD CORPEQX$14.38M0.7%unchanged
IAMGOLD CORPIAG$13.60M0.7%unchanged
JUNIPER NETWORKS INC$9.98M0.5%new
ALPHABET INCGOOG$1.60M0.1%new

What changed since Q1 2025

Against the Q1 2025 filing, Paulson & Co opened 2 new positions, added to 2, trimmed 0, left 11 unchanged and exited 1. Every position is compared, matched on its CUSIP; a change of 2% or less in shares counts as unchanged.

New positions

  • JUNIPER NETWORKS INC$9.98M
  • GOOG$1.60M

Exited

  • INTRA-CELLULAR THERAPIES INCwas $2.84M

Added to

Trimmed

No position was cut by more than 2%.

Other quarters

Source: SEC Form 13F-HR, accession 0001013594-25-001044, filed by PAULSON & CO. INC.. Values are as filed and cover US-listed positions only; a 13F does not show short positions or holdings outside the US. A 13F may be filed up to 45 days after the quarter ends, so the fund may have traded since. Educational information, not financial advice.